iRhythm Technologies
iRhythm Technologies raises $200M Convertible Note at $4B valuation
Quick Facts
iRhythm Technologies: Convertible Note Funding Round
iRhythm Technologies has successfully raised $200M in Convertible Note funding, reaching a valuation of $4B.
Company Overview
Cardiac monitoring solutions
Funding Details
The Convertible Note round was led by CRG LP, with participation from Novo Holdings, Deerfield Management.
Company Information
- Headquarters: 699 8th Street, San Francisco, CA 94103
- Founded: 2006
- Employees: 1000+
- Category: MedTech
Investment
iRhythm Technologies plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- CRG LP: Verified investor in Convertible Note
- Novo Holdings: Verified investor in Convertible Note
- Deerfield Management: Verified investor in Convertible Note
Key Investors
About the Author
Related Company Reports
NeuroLink Brain Raises $580M Series D to Transform Healthcare
NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
MedTech Revolution Secures $890M Series D to Lead MedTech Innovation
MedTech Revolution raises $890M in Series D funding at $13.7B valuation to complete clinical trials for 5 medical devices, scale robotic surgery systems, and expand to asian markets.
ForSight Robotics raises $125M Series B at $700M valuation
ForSight Robotics raises $125M in Series B at $700M valuation. Ophthalmic surgical robots...